-
2023-507254-32-00
5
2024-12-17
Severe hyponatremia and a high risk of rapid SNa overcorrection
-
2023-508724-35-00
4
2024-12-10
Patients with pMMR/MSS metastatic adenocarcinoma of the colon or rectu
-
2023-504713-76-00
5
2024-12-03
Dermatitis atopic
-
2023-506299-28-00
6
2024-12-02
Postoperative pain after cardiac surgery
-
2024-512279-10-00
5
2024-11-25
Triple Negative Breast Cancer
-
2024-514917-36-00
5
2024-11-21
Patients with High Risk Neuroblastoma
-
2023-509912-27-00
5
2024-11-07
Metabolic Dysfunction-Associated Steatotic Liver Disease(MASH) / Nonal
-
2024-516242-19-00
5
2024-11-05
lupus nephritis
-
2023-504620-26-00
4
2024-11-04
Triple negative breast cancer
-
2024-514099-41-00
5
2024-10-31
Alzheimer's disease
-
2023-510395-31-00
5
2024-10-30
Metabolic Dysfunction-Associated Steatohepatitis (MASH) with Compensat
-
2024-514875-16-00
4
2024-10-21
First-line treatment of PD-L1-positive recurrent or metastatic head an
-
2023-504724-25-00
5
2024-10-16
Primary Myelofibrosis
-
2024-515118-42-00
11
2024-09-10
Colorectal cancer
-
2024-517204-11-00
4
2024-08-30
microsatellite stable (MSS) colorectal cancer with liver-dominant meta
-
2024-515297-27-00
5
2024-08-14
colon carcinoma
-
2024-515788-73-00
4
2024-07-30
MICROSATELLITE STABLE (MSS) METASTATIC COLORECTAL CANCER AND
A HIGH IM
-
2023-508100-38-00
5
2024-06-24
Advanced Biliary Cancer (ABC)
-
2023-510140-21-00
6
2024-06-24
Chronic postsurgical pain in non-major scheduled abdominal surgery
-
2023-506590-35-00
4
2024-06-13
Large-Cell NeuroEndocrine
Carcinoma of the lung
-
2023-508154-25-00
6
2024-05-27
Crohn's disease
-
2024-516456-17-00
5
2024-05-07
patients admitted for an obstructive colon cancer
-
2022-502276-23-00
5
2024-04-25
JAK2V617F-positive high-risk Polycythemia Vera
-
2023-506753-38-00
4
2024-04-16
metastatic gastric adenocarcinoma